Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% | |
ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
20646 | TNG908 | 2760481-53-4 | ≧98.0% | |
TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||
20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. | |
CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% | |
Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
20610 | Zavondemstat | 1851412-93-5 | ≧98.0% | |
Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent. | ||||
236271 | TP1287 | 2044686-42-0 | ≧97.0% | |
Alvocidib Prodrug TP-1287 is an orally bioavailable, highly soluble phosphate prodrug | ||||
16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | |
Lirametostat ( CPI-1205 ) is a potent, selective, and cofactor-competitive inhibitor | ||||
230402 | BI 1015550 ( Nerandomilast ) | 1423719-30-5 | ≧98.0% | |
BI 1015550 ( Nerandomilast )is an oral, preferential inhibitor of phosphodiesterase 4 | ||||
20455 | Camlipixant ( BLU-5937 ) | 1621164-74-6 | ≧98.0% | |
Camlipixant is an investigational, twice-daily oral P2X3 receptor antagonist for the | ||||
192142 | Upacicalcet | 1333218-50-0 | ≧98.0% | |
Upacicalcet (formerly SK-1403/AJT240) is a novel non-peptide calcimimetic agent that | ||||
20553 | Tinengotinib ( TT-00420) | 2230490-29-4 | ≧98.0% | |
Tinengotinib ( TT-00420) is a novel multiple kinase inhibitor that strongly inhibited | ||||
2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. | |
Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1